Schedule 13G ownership disclosure

Aptevo Therapeutics Inc.

Security class unavailable · CUSIP: 03835L108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-21-000286
Form type
SC 13G/A
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Feb 16, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub